GlaxoSmithKline Consumer Healthcare Ltd.
5-Day | 712 |
10-Day | 568 |
30-Day | 2,450 |
5-Day | 712 |
10-Day | 568 |
30-Day | 2,450 |
Depth
Market Depth (26 Apr 2018)
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
3 | 5911.00 | 5968.00 | 1 |
5 | 5880.25 | 5970.00 | 10 |
1 | 5868.00 | 5975.00 | 1 |
1 | 5865.00 | 5980.00 | 1 |
2 | 5861.30 | 6005.00 | 2 |
99 | Total | 163 | Total |
Buy Qty
99
Sell QTY
163
5-Day | 20,286 |
10-Day | 32,704 |
30-Day | 27,872 |
5-Day | 20,286 |
10-Day | 32,704 |
30-Day | 27,872 |
- Quote
- CHARTS
- NEWS
- COMMENTS11 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH


Top Trading Ideas
25 April 2018
buy UnitedSpirits Apr Fut |
Entry Price (Rs) 3,506.00 |
Exit Price (Rs) 3,580.00 |
Gain (Rs) 74.00 |
buy BajajFinserv Apr Fut |
Entry Price (Rs) 5,378.00 |
Exit Price (Rs) 5,430.00 |
Gain (Rs) 52.00 |
Days | BSE | NSE |
30 | 6218.47 | 6223.14 |
50 | 6343.14 | 6350.04 |
150 | 6017.25 | 6023.42 |
200 | 5858.94 | 5865.53 |
Click here to view the Open, High, Low, Close, Volume and Spread data for GlaxoSmith Con

Standalone | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
Net Sales | 1,034.67 | 1,115.32 | 985.34 | 1,041.82 |
Other Income | 64.18 | 54.97 | 55.69 | 70.96 |
PBDIT | 204.01 | 261.36 | 166.35 | 217.07 |
Net Profit | 163.66 | 192.41 | 132.23 | 175.88 |
(In Rs Cr)
Total Share Capital | 42.06 |
Net Worth | 3,122.67 |
Total Debt | 0.00 |
Net Block | 487.43 |
Investments | 0.00 |
Total Assets | 3,065.01 |
Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
Nestle | 8734.65 | -1.00 | 9246.35 | 6310.00 | 84,215.75 |
Britannia | 5364.05 | 1.34 | 5445.00 | 3372.00 | 64,400.33 |
GlaxoSmith Con | 5938.05 | 0.88 | 6888.45 | 4856.05 | 24,972.79 |
Varun Beverages | 650.05 | 0.80 | 761.55 | 461.00 | 11,870.86 |
Future Consumer | 60.65 | 2.62 | 79.45 | 29.00 | 11,604.98 |
More » |
Mar' 18 | Jun' 17 | Mar' 17 | Dec' 16 | |
Promoter | 72.46 | 72.46 | 72.46 | 72.46 |
Public (FII + DII) | 27.54 | 27.54 | 27.54 | 27.54 |
Others | 0.00 | 0.00 | 0.00 | 0.00 |
Total | 100.00 | 100.00 | 100.00 | 100.00 |
Scheme | No. of Shares |
ICICI Prudential Balanced Advantage Fund (G) | 179,430 |
ICICI Prudential Balanced Fund (G) | 169,662 |
ICICI Prudential Long Term Equity Fund (Tax Saving) (G) | 164,187 |
SBI Magnum Tax Gain Scheme (G) | 151,398 |
IndusInd Bank Recommended on May 5th 2017
Recommended price 1,423.00 | Peak from reco 1898.00 33.37%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About GlaxoSmith Con
GlaxoSmith Con is in the Food Processing sector. The current market capitalisation stands at Rs 24,972.79 crore.
The company management includes Subodh Bhargava - Chairman, Manoj Kumar - Managing Director, Kunal Kashyap - Director, Naresh Dayal - Director, P Dwarakanath - Director, Anup Dhingra - Director, Vivek Anand - Director, Joaquin B Mascaro - Director, Sangeeta Talwar - Director.
It is listed on the BSE with a BSE Code of 500676 and the NSE with an NSE Code of GSKCONS.
Its Registered office is at Patiala Road, , Nabha,Punjab - 147201.
Their Registrars are Karvy Computershare Private Ltd.
